Study to correlate a new biomarker (ST2) with clinical activity in Ulcerative Colitis patients under golimumab

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-003262-25

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

- To evaluate the correlation of serum soluble ST2 levels with endoscopic activity (endoscopic Mayo score) at week 6 in moderate to severe UC subjects under golimumab treatment. - To evaluate the correlation of serum soluble ST2 with histological activity (Geboes index) at week 6 in moderate to severe UC subjects under golimumab treatment.


Critère d'inclusion

  • Ulcerative colitis

Liens